Chitosan-TPP nanoparticles stabilized by poloxamer for controlling the release and enhancing the bioavailability of doxazosin mesylate: in vitro, and in vivo evaluation-Reference-Cited by-同舟云学术

Chitosan-TPP nanoparticles stabilized by poloxamer for controlling the release and enhancing the bioavailability of doxazosin mesylate: in vitro, and in vivo evaluation

Published:2019-05-03 Issue:7 Volume:45 Page:1130-1139
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Aljaeid Bader M.¹,El-Say Khalid M.¹²^ORCID,Hosny Khaled M.¹³

Affiliation:

1. Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia;

2. Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt;

3. Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2019.1597105

Reference29 articles.

1. Efficacy and Safety of the Doxazosin Gastrointestinal Therapeutic System for the Treatment of Benign Prostate Hyperplasia

2. Clinical correlation of maximal urinary flow rate and plasma doxazosin concentrations in the treatment of benign prostatic hyperplasia

3. Controlled-release doxazosin in the treatment of benign prostatic hyperplasia

4. Preparation and characterization of controlled-release doxazosin mesylate pellets using a simple drug layering-aquacoating technique

5. Emerging micro- and nanotechnology based synthetic approaches for insulin delivery

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Grafting of sinapic acid onto glucosamine nanoparticle as a potential therapeutic drug with enhanced anti-inflammatory activities in osteoarthritis treatment;International Journal of Biological Macromolecules;2023-12

2. The Progress of Chitosan-Based Nanoparticles for Intravesical Bladder Cancer Treatment;Pharmaceutics;2023-01-07

3. Parameters influencing size of electrosprayed chitosan/HPMC/TPP nanoparticles containing alendronate by an artificial neural networks model;Journal of Electrostatics;2021-07

4. Non-Ionic Surfactants for Stabilization of Polymeric Nanoparticles for Biomedical Uses;Materials;2021-06-10

5. Evaluation of nanoparticle drug-delivery systems used in preclinical studies;Therapeutic Delivery;2021-04